343 related articles for article (PubMed ID: 24575854)
21. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
22. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
23. The potential clinical utility of serum alpha-protryptase levels.
Kanthawatana S; Carias K; Arnaout R; Hu J; Irani AM; Schwartz LB
J Allergy Clin Immunol; 1999 Jun; 103(6):1092-9. PubMed ID: 10359891
[TBL] [Abstract][Full Text] [Related]
24. Risk factors for anaphylaxis in patients with mastocytosis.
Górska A; Niedoszytko M; Lange M; Chełmińska M; Nedoszytko B; Wasąg B; Słomiński JM; Gruchała-Niedoszytko M; Nowicki R; Jassem E
Pol Arch Med Wewn; 2015; 125(1-2):46-53. PubMed ID: 25578100
[TBL] [Abstract][Full Text] [Related]
25. Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria/angioedema.
Stoevesandt J; Hain J; Kerstan A; Trautmann A
J Allergy Clin Immunol; 2012 Sep; 130(3):698-704.e1. PubMed ID: 22554708
[TBL] [Abstract][Full Text] [Related]
26. Systemic reactions and anaphylaxis with an acute serum tryptase ≥14 μg/L: retrospective characterisation of aetiology, severity and adherence to National Institute of Health and Care Excellence (NICE) guidelines for serial tryptase measurements and specialist referral.
Srivastava S; Huissoon AP; Barrett V; Hackett S; Dorrian S; Cooke MW; Krishna MT
J Clin Pathol; 2014 Jul; 67(7):614-9. PubMed ID: 24782357
[TBL] [Abstract][Full Text] [Related]
27. Elevated baseline serum tryptase, mastocytosis and anaphylaxis.
Müller UR
Clin Exp Allergy; 2009 May; 39(5):620-2. PubMed ID: 19400907
[No Abstract] [Full Text] [Related]
28. Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome.
Valent P; Bonadonna P; Hartmann K; Broesby-Olsen S; Brockow K; Butterfield JH; Triggiani M; Lyons JJ; Oude Elberink JNG; Arock M; Metcalfe DD; Akin C
Int Arch Allergy Immunol; 2019; 180(1):44-51. PubMed ID: 31256161
[TBL] [Abstract][Full Text] [Related]
29. Mast cell tryptase in sera of patients with Crohn's disease and mastocytosis.
de Rossi TM; Krauss N; Wilken V; Giera B; Konturek PC; Kressel J; Hahn EG; Raithel M
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):273-7. PubMed ID: 19279472
[TBL] [Abstract][Full Text] [Related]
30. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
31. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
32. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
[TBL] [Abstract][Full Text] [Related]
33. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
34. Tryptase values in anaphylaxis and insect allergy.
Bonadonna P; Scaffidi L; Boni E
Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):462-467. PubMed ID: 31306180
[TBL] [Abstract][Full Text] [Related]
35. Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?
Castells MC; Hornick JL; Akin C
J Allergy Clin Immunol Pract; 2015; 3(3):350-5. PubMed ID: 25858055
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
Sonneck K; Florian S; Müllauer L; Wimazal F; Födinger M; Sperr WR; Valent P
Int Arch Allergy Immunol; 2007; 142(2):158-64. PubMed ID: 17057414
[TBL] [Abstract][Full Text] [Related]
37. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
38. Non-allergic, mastocytosis-associated rhinitis.
Dollner R; Taraldsrud E; Iversen K; Osnes T; Kristensen B; Kramer MF
Clin Exp Allergy; 2013 Apr; 43(4):406-12. PubMed ID: 23517036
[TBL] [Abstract][Full Text] [Related]
39. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
40. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.
Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Körner M; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B
J Allergy Clin Immunol; 2009 Nov; 124(5):1047-54. PubMed ID: 19895993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
